Bladder Flat Urothelial Carcinoma In Situ
1 clinical trials · Condition
◉ Watch Bladder Flat Urothelial Carcinoma In Situ
| Record | Firm | Date |
|---|---|---|
| Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer (NCT04164082) | National Cancer Institute (NCI) | 2020-03-18 |
Track Bladder Flat Urothelial Carcinoma In Situ automatically
Every clearance here is in the API, with alerts when new ones post.